Seyedeh Maryam Zekavat, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mendelian Randomization Analysis | 7 | 2024 | 1040 | 0.980 |
Why?
|
Lipoprotein(a) | 4 | 2022 | 490 | 0.800 |
Why?
|
Macular Degeneration | 2 | 2022 | 1016 | 0.790 |
Why?
|
Genome-Wide Association Study | 17 | 2024 | 12801 | 0.780 |
Why?
|
Pneumonia | 3 | 2022 | 2164 | 0.730 |
Why?
|
Retina | 3 | 2024 | 2661 | 0.720 |
Why?
|
Photoplethysmography | 1 | 2019 | 66 | 0.630 |
Why?
|
Coronary Vessel Anomalies | 1 | 2022 | 308 | 0.630 |
Why?
|
Vascular Diseases | 3 | 2022 | 1163 | 0.630 |
Why?
|
Microvessels | 1 | 2021 | 586 | 0.560 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2024 | 16053 | 0.560 |
Why?
|
Deoxyglucose | 1 | 2017 | 333 | 0.540 |
Why?
|
Fingers | 1 | 2019 | 512 | 0.520 |
Why?
|
Genome, Human | 5 | 2020 | 4456 | 0.510 |
Why?
|
Pregnancy in Diabetics | 1 | 2017 | 198 | 0.510 |
Why?
|
Biological Specimen Banks | 6 | 2024 | 789 | 0.470 |
Why?
|
Blood Pressure | 6 | 2024 | 8544 | 0.470 |
Why?
|
Computer Simulation | 2 | 2017 | 6291 | 0.440 |
Why?
|
Coronary Artery Disease | 7 | 2022 | 6569 | 0.420 |
Why?
|
Communicable Diseases | 1 | 2021 | 873 | 0.410 |
Why?
|
Cardiovascular Diseases | 7 | 2024 | 15661 | 0.410 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2055 | 0.400 |
Why?
|
Tomography, Optical Coherence | 2 | 2024 | 2957 | 0.400 |
Why?
|
Mosaicism | 2 | 2024 | 481 | 0.330 |
Why?
|
Menopause, Premature | 2 | 2020 | 124 | 0.320 |
Why?
|
Genetic Predisposition to Disease | 13 | 2024 | 18068 | 0.300 |
Why?
|
Cholesterol | 1 | 2017 | 2913 | 0.290 |
Why?
|
Diabetes, Gestational | 1 | 2017 | 1263 | 0.280 |
Why?
|
Sepsis | 1 | 2021 | 2610 | 0.280 |
Why?
|
Hypertension | 4 | 2022 | 8617 | 0.280 |
Why?
|
Retinal Pigment Epithelium | 2 | 2022 | 309 | 0.270 |
Why?
|
Pregnancy Complications, Cardiovascular | 2 | 2022 | 519 | 0.260 |
Why?
|
Genomics | 1 | 2021 | 5928 | 0.250 |
Why?
|
Receptors, Interleukin-6 | 2 | 2022 | 224 | 0.220 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2019 | 407 | 0.220 |
Why?
|
Multifactorial Inheritance | 3 | 2024 | 1423 | 0.220 |
Why?
|
Apolipoprotein B-100 | 2 | 2021 | 157 | 0.210 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2024 | 87 | 0.210 |
Why?
|
Refraction, Ocular | 1 | 2024 | 188 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 157 | 0.210 |
Why?
|
Coronary Disease | 4 | 2017 | 5919 | 0.200 |
Why?
|
Chromosomes, Human, X | 1 | 2024 | 321 | 0.200 |
Why?
|
Fibrillar Collagens | 1 | 2022 | 42 | 0.200 |
Why?
|
Aging | 1 | 2021 | 8745 | 0.200 |
Why?
|
Sickle Cell Trait | 1 | 2022 | 86 | 0.190 |
Why?
|
Myopia | 1 | 2024 | 254 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 228 | 0.180 |
Why?
|
Genetic Pleiotropy | 1 | 2022 | 181 | 0.180 |
Why?
|
Chromosome Aberrations | 3 | 2022 | 1780 | 0.180 |
Why?
|
Clone Cells | 1 | 2024 | 1670 | 0.180 |
Why?
|
Risk Factors | 16 | 2024 | 74976 | 0.180 |
Why?
|
Aneuploidy | 1 | 2024 | 573 | 0.180 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5176 | 0.180 |
Why?
|
Humans | 53 | 2024 | 768970 | 0.170 |
Why?
|
Digestive System Diseases | 1 | 2021 | 152 | 0.170 |
Why?
|
Hematologic Neoplasms | 2 | 2021 | 1907 | 0.160 |
Why?
|
Disease Susceptibility | 2 | 2023 | 1794 | 0.160 |
Why?
|
Female | 31 | 2024 | 397515 | 0.150 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 255 | 0.150 |
Why?
|
Retinal Ganglion Cells | 1 | 2024 | 811 | 0.150 |
Why?
|
Intraocular Pressure | 1 | 2024 | 1304 | 0.150 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 134 | 0.150 |
Why?
|
Janus Kinase 2 | 1 | 2021 | 560 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2019 | 1758 | 0.150 |
Why?
|
Face | 1 | 2024 | 1031 | 0.140 |
Why?
|
Glaucoma, Open-Angle | 1 | 2024 | 742 | 0.140 |
Why?
|
Rod Cell Outer Segment | 1 | 2017 | 50 | 0.140 |
Why?
|
Middle Aged | 22 | 2024 | 223737 | 0.140 |
Why?
|
Male | 26 | 2024 | 365203 | 0.140 |
Why?
|
Microcirculation | 1 | 2022 | 1281 | 0.140 |
Why?
|
Angiopoietins | 1 | 2017 | 86 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 522 | 0.140 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 303 | 0.130 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2017 | 113 | 0.130 |
Why?
|
Leukocytes | 1 | 2024 | 2034 | 0.130 |
Why?
|
Endothelin-1 | 1 | 2017 | 296 | 0.130 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 520 | 0.130 |
Why?
|
Hematopoiesis | 3 | 2023 | 2059 | 0.120 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2016 | 288 | 0.120 |
Why?
|
Genetic Variation | 3 | 2020 | 6611 | 0.120 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2024 | 1399 | 0.120 |
Why?
|
Open Reading Frames | 1 | 2018 | 818 | 0.120 |
Why?
|
Cholesterol, LDL | 3 | 2019 | 2403 | 0.120 |
Why?
|
Mutation | 8 | 2023 | 30266 | 0.120 |
Why?
|
Dioxygenases | 3 | 2021 | 352 | 0.120 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 706 | 0.120 |
Why?
|
Genotype | 4 | 2022 | 13048 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12253 | 0.110 |
Why?
|
Adult | 17 | 2024 | 223851 | 0.110 |
Why?
|
Obesity, Abdominal | 1 | 2017 | 375 | 0.110 |
Why?
|
Repressor Proteins | 2 | 2021 | 2986 | 0.110 |
Why?
|
Androgens | 1 | 2020 | 1285 | 0.110 |
Why?
|
Odds Ratio | 3 | 2023 | 9684 | 0.110 |
Why?
|
Disease | 1 | 2018 | 673 | 0.100 |
Why?
|
Biological Transport | 1 | 2017 | 2085 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1962 | 0.100 |
Why?
|
Phenotype | 6 | 2020 | 16731 | 0.100 |
Why?
|
Aged | 15 | 2024 | 171786 | 0.100 |
Why?
|
Hematopoietic Stem Cells | 2 | 2021 | 3408 | 0.100 |
Why?
|
Incidence | 5 | 2024 | 21547 | 0.100 |
Why?
|
Proto-Oncogene Proteins | 2 | 2021 | 4528 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3110 | 0.090 |
Why?
|
Postmenopause | 1 | 2020 | 2519 | 0.090 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 1568 | 0.090 |
Why?
|
Gene Expression | 3 | 2019 | 7603 | 0.090 |
Why?
|
Risk Assessment | 4 | 2021 | 24333 | 0.090 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4785 | 0.090 |
Why?
|
Case-Control Studies | 5 | 2019 | 22296 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2145 | 0.090 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1231 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2021 | 2100 | 0.090 |
Why?
|
Lipids | 2 | 2018 | 3345 | 0.090 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 1936 | 0.090 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2133 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2021 | 9618 | 0.080 |
Why?
|
Blood Glucose | 2 | 2021 | 6435 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2015 | 826 | 0.080 |
Why?
|
Nitric Oxide | 1 | 2017 | 2149 | 0.080 |
Why?
|
Atherosclerosis | 2 | 2022 | 3431 | 0.080 |
Why?
|
Health Status | 1 | 2021 | 4095 | 0.080 |
Why?
|
Estonia | 2 | 2018 | 56 | 0.070 |
Why?
|
Veterans | 1 | 2022 | 2672 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2297 | 0.070 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.070 |
Why?
|
Models, Genetic | 3 | 2024 | 3449 | 0.070 |
Why?
|
Proteins | 2 | 2018 | 6011 | 0.070 |
Why?
|
Prospective Studies | 5 | 2022 | 54962 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1304 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3671 | 0.060 |
Why?
|
Signal Transduction | 2 | 2020 | 23653 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3580 | 0.060 |
Why?
|
Axial Length, Eye | 1 | 2024 | 36 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41808 | 0.060 |
Why?
|
Germ-Line Mutation | 2 | 2024 | 1887 | 0.060 |
Why?
|
Aged, 80 and over | 4 | 2021 | 59739 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8088 | 0.050 |
Why?
|
Chromosomes, Human, Y | 1 | 2024 | 164 | 0.050 |
Why?
|
Chromosome Segregation | 1 | 2024 | 230 | 0.050 |
Why?
|
F-Box Proteins | 1 | 2024 | 201 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15471 | 0.050 |
Why?
|
Mass Screening | 1 | 2018 | 5457 | 0.050 |
Why?
|
Mice | 4 | 2023 | 82072 | 0.050 |
Why?
|
Pregnancy | 3 | 2022 | 30265 | 0.050 |
Why?
|
Mucin-5B | 1 | 2022 | 148 | 0.050 |
Why?
|
Choroid | 1 | 2024 | 363 | 0.050 |
Why?
|
Mutation, Missense | 2 | 2024 | 2592 | 0.050 |
Why?
|
Mississippi | 1 | 2021 | 94 | 0.050 |
Why?
|
Gene Frequency | 2 | 2018 | 3626 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 42 | 0.050 |
Why?
|
Myocardial Infarction | 2 | 2019 | 11521 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 406 | 0.040 |
Why?
|
Animals | 6 | 2023 | 169335 | 0.040 |
Why?
|
Nerve Fibers | 1 | 2024 | 709 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2022 | 2748 | 0.040 |
Why?
|
Retinal Degeneration | 1 | 2024 | 414 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 486 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9499 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 325 | 0.040 |
Why?
|
Body Mass Index | 1 | 2017 | 13055 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2017 | 4625 | 0.040 |
Why?
|
United States | 3 | 2021 | 73186 | 0.040 |
Why?
|
Inflammasomes | 1 | 2023 | 540 | 0.040 |
Why?
|
Africa | 1 | 2020 | 726 | 0.040 |
Why?
|
Ovariectomy | 1 | 2019 | 613 | 0.040 |
Why?
|
Heart Failure | 1 | 2021 | 11879 | 0.030 |
Why?
|
Base Sequence | 2 | 2018 | 12430 | 0.030 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.030 |
Why?
|
Demography | 1 | 2021 | 1642 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 2018 | 272 | 0.030 |
Why?
|
Hemoglobins | 1 | 2022 | 1531 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2017 | 370 | 0.030 |
Why?
|
Leukemia | 1 | 2024 | 1520 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2018 | 492 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2016 | 204 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12562 | 0.030 |
Why?
|
Organ Specificity | 1 | 2020 | 1970 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2020 | 1340 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2022 | 39394 | 0.030 |
Why?
|
Prediabetic State | 1 | 2021 | 548 | 0.030 |
Why?
|
Stroke | 1 | 2017 | 9756 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 773 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1056 | 0.030 |
Why?
|
Basophils | 1 | 2016 | 407 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 745 | 0.030 |
Why?
|
Young Adult | 1 | 2021 | 60131 | 0.030 |
Why?
|
Prevalence | 2 | 2021 | 15879 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2019 | 757 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 1514 | 0.030 |
Why?
|
Education | 1 | 2016 | 533 | 0.030 |
Why?
|
Inflammation | 2 | 2023 | 10868 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19023 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6901 | 0.030 |
Why?
|
Leukocyte Count | 1 | 2016 | 1609 | 0.030 |
Why?
|
Nanomedicine | 1 | 2015 | 292 | 0.030 |
Why?
|
Adolescent | 1 | 2021 | 89244 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 771 | 0.030 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4251 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2024 | 2258 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2020 | 1421 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 1682 | 0.020 |
Why?
|
Menopause | 1 | 2019 | 1656 | 0.020 |
Why?
|
Epigenomics | 1 | 2017 | 961 | 0.020 |
Why?
|
Disease Management | 1 | 2022 | 2537 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2081 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 1493 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2893 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1369 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9621 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2464 | 0.020 |
Why?
|
Mice, Nude | 1 | 2015 | 3631 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 30046 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2576 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5622 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3253 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7058 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2603 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10633 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13674 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3612 | 0.020 |
Why?
|
Chromatin | 1 | 2017 | 2981 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9094 | 0.020 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.010 |
Why?
|
Chronic Disease | 1 | 2019 | 9384 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2017 | 3592 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3836 | 0.010 |
Why?
|
DNA | 1 | 2016 | 7214 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9549 | 0.010 |
Why?
|
Hospitalization | 1 | 2022 | 10847 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14484 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2016 | 11684 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22379 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 14201 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40261 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 13091 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26395 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 81903 | 0.010 |
Why?
|